173 related articles for article (PubMed ID: 28435636)
21. Reliability and validity of the Japanese Migraine Disability Assessment (MIDAS) Questionnaire.
Iigaya M; Sakai F; Kolodner KB; Lipton RB; Stewart WF
Headache; 2003 Apr; 43(4):343-52. PubMed ID: 12656705
[TBL] [Abstract][Full Text] [Related]
22. Need for care and perceptions of MIDAS among headache sufferers study.
Stewart W; Lipton R
CNS Drugs; 2002; 16 Suppl 1():5-11. PubMed ID: 12196034
[TBL] [Abstract][Full Text] [Related]
23. Effect of yoga as add-on therapy in migraine (CONTAIN): A randomized clinical trial.
Kumar A; Bhatia R; Sharma G; Dhanlika D; Vishnubhatla S; Singh RK; Dash D; Tripathi M; Srivastava MVP
Neurology; 2020 May; 94(21):e2203-e2212. PubMed ID: 32376640
[TBL] [Abstract][Full Text] [Related]
24. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score.
Stewart WF; Lipton RB; Whyte J; Dowson A; Kolodner K; Liberman JN; Sawyer J
Neurology; 1999 Sep; 53(5):988-94. PubMed ID: 10496257
[TBL] [Abstract][Full Text] [Related]
25. A comparative study on the effectiveness of topiramate and propranolol in patients with migraine with aura.
Mohammadianinejad SE; Rafie S; Farashi S
Curr J Neurol; 2022 Jan; 21(1):7-11. PubMed ID: 38011452
[No Abstract] [Full Text] [Related]
26. Headache management program improves outcome for chronic headache.
Harpole LH; Samsa GP; Jurgelski AE; Shipley JL; Bernstein A; Matchar DB
Headache; 2003; 43(7):715-24. PubMed ID: 12890125
[TBL] [Abstract][Full Text] [Related]
27. Validity, reliability and application of the taiwan version of the migraine disability assessment questionnaire.
Hung PH; Fuh JL; Wang SJ
J Formos Med Assoc; 2006 Jul; 105(7):563-8. PubMed ID: 16877236
[TBL] [Abstract][Full Text] [Related]
28. The application of Orem's Self-Care Model to burn care.
Wilson J; Gramling L
J Burn Care Res; 2009; 30(5):852-8. PubMed ID: 19692925
[TBL] [Abstract][Full Text] [Related]
29. Use of the Migraine Disability Assessment Questionnaire in children and adolescents with headache: an Italian pilot study.
D'Amico D; Grazzi L; Usai S; Andrasik F; Leone M; Rigamonti A; Bussone G
Headache; 2003; 43(7):767-73. PubMed ID: 12890131
[TBL] [Abstract][Full Text] [Related]
30. Levetiracetam in Compare to Sodium Valproate for Prophylaxis in Chronic Migraine Headache: A Randomized Double-Blind Clinical Trial.
Kashipazha D; Ghadikolaei HS; Siavashi M
Curr Clin Pharmacol; 2017; 12(1):55-59. PubMed ID: 28356053
[TBL] [Abstract][Full Text] [Related]
31. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
[TBL] [Abstract][Full Text] [Related]
32. Reliability of the migraine disability assessment score in a population-based sample of headache sufferers.
Stewart WF; Lipton RB; Kolodner K; Liberman J; Sawyer J
Cephalalgia; 1999 Mar; 19(2):107-14; discussion 74. PubMed ID: 10214536
[TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
34. Orem's Self-Care Model With Trauma Patients: A Quasi-Experimental Study.
Khatiban M; Shirani F; Oshvandi K; Soltanian AR; Ebrahimian R
Nurs Sci Q; 2018 Jul; 31(3):272-278. PubMed ID: 29916324
[TBL] [Abstract][Full Text] [Related]
35. Clinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) questionnaire.
Lipton RB; Stewart WF; Sawyer J; Edmeads JG
Headache; 2001 Oct; 41(9):854-61. PubMed ID: 11703471
[TBL] [Abstract][Full Text] [Related]
36. The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial.
Ghorbani Z; Rafiee P; Fotouhi A; Haghighi S; Rasekh Magham R; Ahmadi ZS; Djalali M; Zareei M; Razeghi Jahromi S; Shahemi S; Mahmoudi M; Togha M
J Headache Pain; 2020 Feb; 21(1):22. PubMed ID: 32093657
[TBL] [Abstract][Full Text] [Related]
37. Validity and reliability of Turkish translation of Migraine Disability Assessment (MIDAS) questionnaire in patients with migraine.
Gedikoglu U; Coskun O; Inan LE; Ucler S; Tunc T; Emre U
Cephalalgia; 2005 Jun; 25(6):452-6. PubMed ID: 15910570
[TBL] [Abstract][Full Text] [Related]
38. A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability.
Lipton RB; Manack Adams A; Buse DC; Fanning KM; Reed ML
Headache; 2016 Sep; 56(8):1280-9. PubMed ID: 27349336
[TBL] [Abstract][Full Text] [Related]
39. Effect of Soft Tissue Techniques on Headache Impact, Disability, and Quality of Life in Migraine Sufferers: A Pilot Study.
Espí-López GV; Ruescas-Nicolau MA; Nova-Redondo C; Benítez-Martínez JC; Dugailly PM; Falla D
J Altern Complement Med; 2018 Nov; 24(11):1099-1107. PubMed ID: 29708766
[TBL] [Abstract][Full Text] [Related]
40. MIDAS and HIT-6 French translation: reliability and correlation between tests.
Magnoux E; Freeman MA; Zlotnik G
Cephalalgia; 2008 Jan; 28(1):26-34. PubMed ID: 17970768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
